Latest News
Quidel Announces Preliminary Revenue for Fourth Quarter 2018
SAN DIEGO--(BUSINESS WIRE)--Jan. 7, 2019--
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a
provider of rapid diagnostic testing solutions, cellular-based virology
assays and molecular diagnostic systems, announced today that it expects
revenues in the fourth quarter of 2018 to be in the range of
million to $133 million
Careers
Are you a determined, optimistic, team player? Quidel is looking for talented innovators who want to be part of revolutionizing medical diagnostics.
Support
To place orders, get assistance with shipments, pricing or contract administration view our Customer Support page.
Visit our Technical Support page to get help with product specifications, supporting docs or general support issues.
NEW: Register at MyQuidel.com to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.